BLOOMIN BRANDS INC (BLMN) — insider trading
Consumer Discretionary · NASDAQ
BLOOMIN BRANDS INC (BLMN) has 30 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 30 (latest 2026-04-22).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-22 | Sagal Jonathan | Director | Option exercise / conversion (derivative) | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Sagal Jonathan | Director | Option exercise / conversion | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Keating Colleen | Director | Option exercise / conversion (derivative) | 5,592 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Keating Colleen | Director | Grant / award / vesting (derivative) | 23,485 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Keating Colleen | Director | Option exercise / conversion | 5,592 | $0.00 | $0 | Form 4 |
| 2026-04-22 | MOHAN RAJENDRA M | Director, Other | Option exercise / conversion (derivative) | 30,574 | $0.00 | $0 | Form 4 |
| 2026-04-22 | MOHAN RAJENDRA M | Director, Other | Grant / award / vesting (derivative) | 38,637 | $0.00 | $0 | Form 4 |
| 2026-04-22 | MOHAN RAJENDRA M | Director, Other | Option exercise / conversion | 30,574 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Marein-Efron Melanie | Director | Option exercise / conversion (derivative) | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Marein-Efron Melanie | Director | Grant / award / vesting (derivative) | 23,485 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Marein-Efron Melanie | Director | Option exercise / conversion | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Lal Rohit | Director | Option exercise / conversion (derivative) | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Lal Rohit | Director | Grant / award / vesting (derivative) | 23,485 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Lal Rohit | Director | Option exercise / conversion | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | DINKINS JAMES L | Director | Option exercise / conversion (derivative) | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | DINKINS JAMES L | Director | Grant / award / vesting (derivative) | 23,485 | $0.00 | $0 | Form 4 |
| 2026-04-22 | DINKINS JAMES L | Director | Option exercise / conversion | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | MAHONEY JOHN | Director | Option exercise / conversion (derivative) | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | MAHONEY JOHN | Director | Grant / award / vesting (derivative) | 23,485 | $0.00 | $0 | Form 4 |
| 2026-04-22 | MAHONEY JOHN | Director | Option exercise / conversion | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Kunkel Julie T. | Director | Option exercise / conversion (derivative) | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Kunkel Julie T. | Director | Grant / award / vesting (derivative) | 23,485 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Kunkel Julie T. | Director | Option exercise / conversion | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | GEORGE DAVID C | Director | Option exercise / conversion (derivative) | 25,478 | $0.00 | $0 | Form 4 |
| 2026-04-22 | GEORGE DAVID C | Director | Grant / award / vesting (derivative) | 23,485 | $0.00 | $0 | Form 4 |
| 2026-04-22 | GEORGE DAVID C | Director | Option exercise / conversion | 25,478 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Levy Tara Walpert | Director | Option exercise / conversion (derivative) | 19,746 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Levy Tara Walpert | Director | Option exercise / conversion | 19,746 | $0.00 | $0 | Form 4 |
| 2026-03-11 | Lal Rohit | Director | Open-market purchase | 10,000 | $5.69 | $56.9K | Form 4 |
| 2026-03-05 | Kunkel Julie T. | Director | Open-market purchase | 1,000 | $6.46 | $6.5K | Form 4 |
Ask the chat about BLMN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: BLOOMIN BRANDS INC (BLMN).
Last updated 2026-04-22 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.